Catalent | Pasivo Circulante



Current Liabilities Cambio Fecha
Agilent USD 2.01B 143M 2025-04
AstraZeneca USD 29.13B 1.26B 2025-03
Bristol-Myers Squibb USD 24.07B 296M 2025-03
Bruker USD 1.34B 60.3M 2025-03
Centene USD 37.14B 2.88B 2025-03
Charles River Laboratories USD 1.05B 56.95M 2025-03
Cigna USD 55.74B 2.23B 2025-03
Danaher USD 6.64B 153M 2025-03
Dentsply International USD 1.79B 204M 2025-03
Elevance Health 40.36B 1.67B 2024-12
Eli Lilly USD 30.07B 1.69B 2025-03
Glaxosmithkline GBP 21.7B 238M 2024-12
Hologic USD 989.7M 12.7M 2025-03
Humana 16.94B 1.79B 2024-12
Illumina USD 1.44B 107M 2025-03
Intuitive Surgical USD 2.01B 200.9M 2025-03
IQVIA Holdings USD 7.18B 222M 2025-03
J&J USD 56.9B 6.58B 2025-03
Laboratory Of America USD 2.06B 1.27B 2025-03
Lonza CHF 3.58B 970M 2024-12
McKesson USD 61.6B 3.04B 2025-03
Merck EUR 9.5B 1.79B 2025-03
Merck USD 25.17B 3.25B 2025-03
Mettler Toledo International USD 1.15B 18.5M 2025-03
Novartis USD 28.69B 560M 2024-12
Pfizer USD 36.45B 6.54B 2025-03
Quest Diagnostics USD 1.44B 728M 2025-03
Repligen USD 152M 25.21M 2025-03
Revvity USD 648.19M 4.91M 2025-03
Roche Holding CHF 27.02B 424M 2024-12
Supernus Pharmaceuticals USD 292.4M 889K 2024-12
Thermo Fisher Scientific USD 13.17B 158M 2025-03
UnitedHealth 103.77B 2.2B 2024-12
Waters USD 960.97M 171.21M 2025-03
West Pharmaceutical Services USD 526.7M 23.7M 2025-03



Catalent Pasivo Circulante - Los valores actuales, los datos históricos, las previsiones, estadísticas, gráficas y calendario económico - Jul 2025.